Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Latanoprost Punctal Plug Delivery System in Ocular Hypertension or Open-Angle Glaucoma
NCT00855517Phase 2Withdrawn
- Sponsor
- Mati Therapeutics
- Start
- Mar 2009
- Primary completion
- Jul 2009
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of latanoprost in ocular hypertension, open-angle glaucoma (OAG), sponsored by Mati Therapeutics. Planned start Mar 2009; status: withdrawn.
02
Drugs
latanoprost
03
Conditions
ocular hypertensionopen-angle glaucoma (OAG)
Beyond the preview
Go deeper on NCT00855517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00855517.